Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

F127 poloxamer effect on cytotoxicity induction of tumour cell cultures treated with doxorubicin.

Gentile EA, Castronuovo CC, Cuestas ML, Gómez N, Davio C, Oubiña JR, Mathet VL.

J Pharm Pharmacol. 2019 Nov;71(11):1655-1662. doi: 10.1111/jphp.13158. Epub 2019 Aug 27.

PMID:
31456253
2.

Hepatitis D virus infection in patients with hepatitis B virus occult infection.

Oubiña JR, Delfino CM, Mathet VL.

Eur J Gastroenterol Hepatol. 2019 May;31(5):646. doi: 10.1097/MEG.0000000000001362. No abstract available.

PMID:
30920483
3.

Synthesis of New Indanyl Nucleoside Analogues and their Biological Evaluation on Hepatitis C Virus (HCV) Replicon.

Gómez ME, Gentile EA, Martini MF, Cuestas ML, Mathet VL, Moltrasio GY, Moglioni AG.

Molecules. 2019 Mar 11;24(5). pii: E990. doi: 10.3390/molecules24050990.

4.

A comprehensive bioinformatic analysis of hepatitis D virus full-length genomes.

Delfino CM, Cerrudo CS, Biglione M, Oubiña JR, Ghiringhelli PD, Mathet VL.

J Viral Hepat. 2018 Jul;25(7):860-869. doi: 10.1111/jvh.12876. Epub 2018 Feb 21.

PMID:
29406571
5.

Effect of several PEO-PPO amphiphiles on bax, bcl-2, and hTERT mRNAs: An insight into apoptosis and cell immortalization induced in hepatoma cells by these polymeric excipients.

Castronuovo CC, Cuestas ML, Oubiña JR, Mathet VL.

Biotechnol Appl Biochem. 2016 Mar-Apr;63(2):273-80. doi: 10.1002/bab.1352. Epub 2015 May 14.

PMID:
25630439
6.

First hepatitis B virus full-length genomic study among blood donors from Argentina: unexpected mutations in the circulating subgenotypes' proteins.

Delfino CM, Berini C, Pedrozo W, Malan R, Blejer J, Oubiña JR, Biglione MM, Mathet VL.

Virus Genes. 2015 Apr;50(2):286-91. doi: 10.1007/s11262-014-1159-4. Epub 2014 Dec 24.

PMID:
25537951
7.

Hepatitis B virus and hepatitis D virus in blood donors from Argentina: circulation of HBsAg and reverse transcriptase mutants.

Delfino CM, Gentile EA, Castillo AI, Cuestas ML, Pataccini G, Cánepa C, Malan R, Blejer J, Berini C, Eirin ME, Pedrozo W, Oubiña JR, Biglione MM, Mathet VL.

Arch Virol. 2014 May;159(5):1109-17. doi: 10.1007/s00705-013-1917-y. Epub 2013 Dec 4.

PMID:
24306325
8.

Dissimilar expression of multidrug resistance mdr1 and bcrp by the replication of hepatitis C virus: role of the nonstructural 5A protein.

W Rivero C, Rosso N, Gentile E, Cuestas M, Tiribelli C, Oubiña JR, Mathet VL.

J Viral Hepat. 2013 Apr;20(4):e127-30. doi: 10.1111/jvh.12028. Epub 2012 Nov 28.

PMID:
23490381
9.

Downregulation of mdr1 and abcg2 genes is a mechanism of inhibition of efflux pumps mediated by polymeric amphiphiles.

Cuestas ML, Castillo AI, Sosnik A, Mathet VL.

Bioorg Med Chem Lett. 2012 Nov 1;22(21):6577-9. doi: 10.1016/j.bmcl.2012.09.012. Epub 2012 Sep 13.

PMID:
23031592
10.

Specific primer sets used to amplify by PCR the hepatitis B virus overlapping S/Pol region select different viral variants.

Cuestas ML, Mathet VL, Oubiña JR.

J Viral Hepat. 2012 Oct;19(10):754-6. doi: 10.1111/j.1365-2893.2012.01614.x. Epub 2012 Jul 17.

PMID:
22967107
11.

Antiviral activity against the hepatitis C virus (HCV) of 1-indanone thiosemicarbazones and their inclusion complexes with hydroxypropyl-β-cyclodextrin.

Glisoni RJ, Cuestas ML, Mathet VL, Oubiña JR, Moglioni AG, Sosnik A.

Eur J Pharm Sci. 2012 Oct 9;47(3):596-603. doi: 10.1016/j.ejps.2012.07.018. Epub 2012 Aug 3.

PMID:
22885176
12.

HDAg-L variants in covert hepatitis D and HBV occult infection among Amerindians of Argentina: new insights.

Delfino CM, Eirin ME, Berini C, Malan R, Gentile E, Castillo A, Pedrozo W, Krupp R, Blejer J, Oubiña JR, Mathet VL, Biglione MM.

J Clin Virol. 2012 Jul;54(3):223-8. doi: 10.1016/j.jcv.2012.04.014. Epub 2012 May 16.

PMID:
22608280
13.

New natural variants of hepatitis B virus among Amerindians from Argentina with mainly occult infections.

Delfino CM, Berini C, Eirin ME, Malan R, Pedrozo W, Krupp R, Blejer J, Espejo R, Fierro L, Puca A, Oubiña JR, Mathet VL, Biglione MM.

J Clin Virol. 2012 Jun;54(2):174-9. doi: 10.1016/j.jcv.2012.02.023. Epub 2012 Mar 22.

PMID:
22445262
14.

Poloxamines display a multiple inhibitory activity of ATP-binding cassette (ABC) transporters in cancer cell lines.

Cuestas ML, Sosnik A, Mathet VL.

Mol Pharm. 2011 Aug 1;8(4):1152-64. doi: 10.1021/mp2000132. Epub 2011 Jun 7.

PMID:
21591727
15.

Naturally occurring hepatitis B virus (HBV) variants with primary resistance to antiviral therapy and S-mutants with potential primary resistance to adefovir in Argentina.

Cuestas ML, Rivero CW, Minassian ML, Castillo AI, Gentile EA, Trinks J, León L, Daleoso G, Frider B, Lezama C, Galoppo M, Giacove G, Mathet VL, Oubiña JR.

Antiviral Res. 2010 Jul;87(1):74-7. doi: 10.1016/j.antiviral.2010.04.005. Epub 2010 Apr 18.

PMID:
20403388
16.

GB virus C quasispecies detected in plasma and lymphocyte subsets in a natural human infection.

Ruiz V, Giordano M, Rivero CW, Minassian ML, Cuestas ML, Trinks J, Mathet VL, Oubiña JR.

J Gen Virol. 2010 Jul;91(Pt 7):1687-92. doi: 10.1099/vir.0.019877-0. Epub 2010 Mar 24.

PMID:
20335494
17.

Drug delivery systems and liver targeting for the improved pharmacotherapy of the hepatitis B virus (HBV) infection.

Cuestas ML, Mathet VL, Oubiña JR, Sosnik A.

Pharm Res. 2010 Jul;27(7):1184-202. doi: 10.1007/s11095-010-0112-z. Epub 2010 Mar 24. Review.

PMID:
20333454
18.

Single and multiple mutations in the human cytomegalovirus UL97 gene and their relationship to the enzymatic activity of UL97 kinase for ganciclovir phosphorylation.

Sanchez Puch SI, Mathet VL, Porta M, Cuestas ML, Oubiña JR, Videla CM, Salomón HE.

Antiviral Res. 2009 Nov;84(2):194-8. doi: 10.1016/j.antiviral.2009.08.005. Epub 2009 Aug 25.

PMID:
19712701
19.

Two simultaneous hepatitis B virus epidemics among injecting drug users and men who have sex with men in Buenos Aires, Argentina: characterization of the first D/A recombinant from the American continent.

Trinks J, Cuestas ML, Tanaka Y, Mathet VL, Minassian ML, Rivero CW, Benetucci JA, Gímenez ED, Segura M, Bobillo MC, Corach D, Ghiringhelli PD, Sánchez DO, Avila MM, Peralta LA, Kurbanov F, Weissenbacher MC, Simmonds P, Mizokami M, Oubiña JR.

J Viral Hepat. 2008 Nov;15(11):827-38. doi: 10.1111/j.1365-2893.2008.00997.x. Epub 2008 May 27.

PMID:
18507755
20.
21.
22.

Dynamics of a hepatitis B virus e antigen minus population ascribed to genotype F during the course of a chronic infection despite the presence of anti-HBs antibodies.

Mathet VL, López JL, Ruiz V, Sánchez DO, Carballal G, Campos RH, Oubiña JR.

Virus Res. 2007 Jan;123(1):72-85. Epub 2006 Sep 18.

PMID:
16979773
23.

Detection of hepatitis B virus (HBV) genotype E carried--even in the presence of high titers of anti-HBs antibodies--by an Argentinean patient of African descent who had received vaccination against HBV.

Mathet VL, Cuestas ML, Ruiz V, Minassian ML, Rivero C, Trinks J, Daleoso G, León LM, Sala A, Libellara B, Corach D, Oubiña JR.

J Clin Microbiol. 2006 Sep;44(9):3435-9.

24.

Unusual naturally occurring humoral and cellular mutated epitopes of hepatitis B virus in a chronically infected argentine patient with anti-HBs antibodies.

Cuestas ML, Mathet VL, Ruiz V, Minassian ML, Rivero C, Sala A, Corach D, Alessio A, Pozzati M, Frider B, Oubiña JR.

J Clin Microbiol. 2006 Jun;44(6):2191-8.

25.

Design, development and evaluation of a competitive RT-PCR for quantitation of GBV-C RNA.

Ruiz V, Espínola L, Mathet VL, Perandones CE, Oubiña JR.

J Virol Methods. 2006 Sep;136(1-2):58-64. Epub 2006 May 23.

PMID:
16716411
26.

Phylogenetic and mathematical analyses for investigating putative mother-to-infant transmission chains when only GB virus C (hepatitis G virus) 5' noncoding region sequences are available.

Mathet VL, Espínola L, Ruiz V, Maríncola A, Quarleri JF, Ceballos A, Peralta LA, Natal M, Haedo A, Sánchez DO, Oubiña JR.

J Clin Microbiol. 2003 Sep;41(9):4489-91. No abstract available.

27.

In vitro detection of dissimilar amounts of hepatitis C virus (HCV) subtype-specific RNA genomes in mixes prepared from sera of persons infected with a single HCV genotype.

Quarleri JF, Bussy MV, Mathet VL, Ruiz V, Iácono R, Lu L, Robertson BH, Oubiña JR.

J Clin Microbiol. 2003 Jun;41(6):2727-33.

28.

Hepatitis B virus S gene mutants in a patient with chronic active hepatitis with circulating Anti-HBs antibodies.

Mathet VL, Feld M, Espínola L, Sánchez DO, Ruiz V, Mandó O, Carballal G, Quarleri JF, D'Mello F, Howard CR, Oubiña JR.

J Med Virol. 2003 Jan;69(1):18-26.

PMID:
12436473
29.

Hepatitis C virus and GBV-C/hepatitis G virus in Argentine patients with porphyria cutanea tarda.

Oubiña JR, Quarleri JF, Sawicki MA, Mathet VL, Ruiz V, Schroder T, Méndez M, Parera V, Muramatsu H, Battle A, González Cappa SM, Fainboim HA.

Intervirology. 2001;44(4):215-8.

PMID:
11509882
30.

Genomic and phylogenetic analysis of hepatitis C virus isolates from argentine patients: a six-year retrospective study.

Quarleri JF, Robertson BH, Mathet VL, Feld M, Espínola L, Requeijo MP, Mandó O, Carballal G, Oubiña JR.

J Clin Microbiol. 2000 Dec;38(12):4560-8. Erratum in: J Clin Microbiol 2001 Mar;39(3):1208-10.

31.

GB virus C/hepatitis G virus groups and subgroups: classification by a restriction fragment length polymorphism method based on phylogenetic analysis of the 5' untranslated region.

Quarleri JF, Mathet VL, Feld M, Ferrario D, della Latta MP, Verdun R, Sánchez DO, Oubiña JR.

J Clin Microbiol. 1999 May;37(5):1340-7.

Supplemental Content

Loading ...
Support Center